16 estimates ahead of Novo Nordisk report
Ahead of Novo Nordisk's report on February 5, investors on Pinpoint Estimates anticipate revenue and earnings to fall within the following weighted ranges:
Net sales: 75,85 - 79,81 MDDKK
EBIT: 31,37 - 34,19 MDDKK
The data is based on estimates from 16 investors. Visit pinpointestimates.com to access Pinpoint’s consensus figure and other investors' estimates ahead of the report.
Pinpoint Estimates is an open platform that compiles estimates from investors and analysts ahead of publicly traded companies' quarterly and annual reports. Contributors are given different weights in the consensus based on their historical accuracy.